GoingToMeet

Conference on Biobanking Americas ( Conference and Workshop Only )
The future for next generation drug discovery and personalised medicines
To be held at 9th - 11th November 2010, Boston, USA

Key Speakers
• Dr. Marc Allard, Research Microbiologist, Center for Food Safety and Applied Nutrition, FDA
• Dr. Adel Laoui, Director, Healthcare Technologies Aging Therapeutic Strategic Unit, Sanofi-aventis
• Brenda Yanak, West Point IT Site Head and Account Manager, Franchise Biology, siRNA, Imaging, and GeM, Merck
• Jeff Milton, Bioinformatics & Computational Biology, Genentech
• Dr. John G. Baust, UNESCO Chair & Professor, Director, Institute of Biomedical Technology, State University of New York
• Elaine W. Gunter, Founder and President, Specimen Solutions, LLC, National Cancer Institute
• Dr. Hartmut Juhl, CEO, Indivumed
• James Eliason, Director, Stem Cell Commercialization Center
• Dr. Michael Hehenberger, Business Development Executive, Life Sciences, IBM Thomas J. Watson Research Center
• Kristen Rosati, Partner, Coppersmith Schermer & Brockelman
• Dr. Richard J. Maguire, Director of Business Development – LIMS, Ocimum

An estimated $1bn has been invested in the biobanking industry within the last ten years. At least 179 biobanks with 345,000 donors exist in the US, most of which were established in the last 10 years. (Source: Business Insights, March 2009)